FGF21 and Cardiac Physiopathology
نویسندگان
چکیده
The heart is not traditionally considered either a target or a site of fibroblast growth factor-21 (FGF21) production. However, recent findings indicate that FGF21 can act as a cardiomyokine; that is, it is produced by cardiac cells at significant levels and acts in an autocrine manner on the heart itself. The heart is sensitive to the effects of FGF21, both systemic and locally generated, owing to the expression in cardiomyocytes of β-Klotho, the key co-receptor known to confer specific responsiveness to FGF21 action. FGF21 has been demonstrated to protect against cardiac hypertrophy, cardiac inflammation, and oxidative stress. FGF21 expression in the heart is induced in response to cardiac insults, such as experimental cardiac hypertrophy and myocardial infarction in rodents, as well as in failing human hearts. Intracellular mechanisms involving PPARα and Sirt1 mediate transcriptional regulation of the FGF21 gene in response to exogenous stimuli. In humans, circulating FGF21 levels are elevated in coronary heart disease and atherosclerosis, and are associated with a higher risk of cardiovascular events in patients with type 2 diabetes. These findings provide new insights into the role of FGF21 in the heart and may offer potential therapeutic strategies for cardiac disease.
منابع مشابه
Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation
Diabetic cardiomyopathy (DCM) is one of the major causes of morbidity and mortality in diabetic patients. Recent studies have demonstrated an increased level of fibroblast growth factor 21 (FGF21) in the plasma of DCM patients, and FGF21 has been proven to be a cardiovascular protector of the heart. The present study aimed to further investigate the pathogenic role of FGF21 in DCM, hypothesizin...
متن کاملCardiac Fgf21 synthesis and release: an autocrine loop for boosting up antioxidant defenses in failing hearts.
Fibroblast growth factors (Fgfs) are signalling proteins of 150–300 amino acids with diverse functions, mainly in development and metabolism. The human/mouse Fgf family comprises 22 members. Fgfs can be classified as intracellular, paracrine, and endocrine Fgfs by their action mechanisms. Among Fgfs, Fgf2, Fgf16, Fgf21, and Fgf23 have been shown to be cardiomyokines playing pathophysiological r...
متن کاملNovel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
AIMS Fibroblast growth factor 21 (FGF21) is a hepatic metabolic regulator with pleotropic actions. Its plasma concentrations are increased in obesity and diabetes; states associated with an increased incidence of cardiovascular disease. We therefore investigated the direct effect of FGF21 on cardio-protection in obese and lean hearts in response to ischemia. METHODS AND RESULTS FGF21, FGF21-r...
متن کاملFibroblast growth factor 21 protects the heart from oxidative stress.
AIMS Oxidative stress mediated by reactive oxygen species (ROS) plays a striking role in the pathogenesis of heart failure, and antioxidants have been shown to attenuate cardiac remodelling in experimental models of cardiac damage. We recently showed that fibroblast growth factor 21 (Fgf21) is produced by the heart and exerts protective effects, preventing cardiac hypertrophy development. The a...
متن کاملContribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
AIM The relationship between fibroblast growth factor 21 (FGF21) and cardiovascular disease has been well established in recent studies. This study aimed to investigate the relationship between FGF21 and left ventricular systolic dysfunction and cardiac death. METHODS Two-dimensional echocardiography was used to measure the left ventricular ejection fraction (LVEF) to estimate left ventricula...
متن کامل